Skip To Main Content
Mira V Han on Muck Rack

Mira V Han

Las Vegas
As seen in: Nature, MDPI, BioRxiv, Texas Medical Center, Pharmaceutical Online, Bioprocess Online, Outsourced Pharma
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mira V

Contact Mira V, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prediction of postoperative intracerebral hemorrhage following brain biopsy using integrated statistical and machine learning analyses

|
By Jaewon Choi, Mira V Han, Sun Mo Nam, Jong Ha Hwang, Boa Jang, Min-Sung Sean Kim, Yong Kim, Chul-Kee Park, Young-gon Kim, Yoon Hwan Byun, Byungjun Woo, Hye Seok Park
| Nature Verified
Abstract Postoperative intracerebral hemorrhage (P-ICH) is the most common complication of brain biopsy, yet predictors of clinically significant symptomatic events remain poorly defined. We performed a retrospective dual-center cohort study of 464 consecutive adult patients undergoing brain biopsy between 2014 and 2024. P-ICH was classified by clinical severity (none, asymptomatic, symptomatic) and timing (immediate or delayed).
Open in Who Shared Issue with article?

11.11.25 -- Supporting The Next Generation Of ADCs

|
By Tyler Menichiello Verified, Mira V Han, Clemens Jakobi
| Bioprocess Online Verified
With more than 65 years of sterile injectable manufacturing experience, Simtra BioPharma Solutions offers world-class GMP sterile fill and finish services, deep scientific and technical expertise, and a uniquely collaborative approach to support our customers’ strategic objectives.
Open in Who Shared Issue with article?

Building A Path To Approval With Effective Regulatory Support Original

|
By Mira V Han, Lead Urban Specialist, Louis Garguilo Verified
| Outsourced Pharma
By Mira Han, Lead Specialist in Regulatory Affairs, Samsung Biologics Adopting a right-the-first-time approach throughout development, manufacturing, and regulatory compliance is critical to minimizing risk, optimizing efficiency, and ensuring the successful approval of novel biopharmaceuticals. Each stage of the biologics lifecycle — from cell line development to commercial production — presents opportunities for delays, deviations, or compliance challenges that can impact timelines and costs.
Open in Who Shared View Duplicates (2) Issue with article?
See all 8 articles